Jaisel Patel

Jaisel’s experience includes advising:

• Thoma Bravo in a number of matters, including:
  • Its sale of Adenza, a leading provider of mission-critical risk management and regulatory reporting software to the financial services industry, to Nasdaq (NASDAQ: NDAQ) for US$10.5 billion*
  • Imprivata, a portfolio company of Thoma Bravo, in its acquisition of SecureLink, a leader in critical access management*
  • Its acquisition of Bluesight, the Medication Intelligence™ Company*
  • Bluesight’s acquisition of Medacist, a pioneer in drug diversion monitoring*
• Instructure (NYSE: INST), the learning platform and maker of Canvas, in its acquisition of Parchment, the world’s largest academic credential management platform and network, for US$835 million*
• Zelis, a leading provider of healthcare technology solutions, in connection with:
  • Its acquisition of PaySpan, a leader in healthcare electronic payment and reimbursement automation services*
  • Its acquisition of Payer Compass, a leading healthcare provider of reimbursement and claims pricing, administration and processing solutions*
• Dunes Point Capital, LP in connection with:
  • Its acquisition of Eastern Communications, Ltd., a leading national distributor and technical service provider of mission-critical communication devices and network infrastructure*
  • Its acquisition of Greenwood Industries, LLC, a leading provider of aftermarket commercial roofing and building envelope services*
• KKR-backed Genesis Care Pty Ltd and its affiliates in their chapter 11 bankruptcy cases and sale of its US radiation oncology assets*
• Periscope Equity in its acquisition of The RepTrak Company™, the global leader in reputation intelligence*
• Private equity sponsor in its acquisition of a minority interest in a leading orthopedic services provider*
• Private equity sponsor in its acquisition of a municipal recycling company*
• Private medical transportation company in its acquisition of a leading broker in the medical transportation industry*
• SilverCloud Health, a leading on-demand digital mental health platform, in its sale to Amwell (NYSE: AMWL)*

*Matter handled prior to joining Latham